Adverum Biotechnologies Inc (ADVM)
6.04
+0.29
(+5.04%)
USD |
NASDAQ |
Nov 22, 16:00
6.05
+0.01
(+0.17%)
After-Hours: 20:00
Adverum Biotechnologies Revenue (Annual): 3.60M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.60M |
| December 31, 2022 | |
| December 31, 2021 | 7.50M |
| December 31, 2020 | |
| December 31, 2019 | 0.25M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.612M |
| December 31, 2017 | 1.849M |
| December 31, 2016 | 1.455M |
| December 31, 2015 | 2.319M |
| December 31, 2014 | 0.572M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.25M
Minimum
2019
7.50M
Maximum
2021
3.783M
Average
3.60M
Median
2023
Revenue (Annual) Benchmarks
| EyePoint Pharmaceuticals Inc | 46.02M |
| Cassava Sciences Inc | -- |
| Regenxbio Inc | 90.24M |
| Editas Medicine Inc | 78.12M |
| Apellis Pharmaceuticals Inc | 396.59M |